New primary monoclonal antibodies · 08. July 2025
SYnAbs innovative mouse and rat RUO monoclonals to detect MRSA strains targeting PBP2a and PBP2b for diagnosis in lateral flow immunoassay
Secondary monoclonal antibodies · 02. July 2025
MARK is a high-specificity mouse monoclonal antibody developed by SynAbs to target the κ light chain of rat immunoglobulins (Igκ). Designed for Research Use Only (RUO), MARK serves critical functions in:
✅ Immunoassays: as a secondary antibody in ELISA, Western blot, and flow cytometry
✅ Antibody purification: in immunoaffinity chromatography using Sepharose coupling
✅ Lateral flow tests (LFIAs): as a control line capture antibody for rat monoclonal detection
Secondary monoclonal antibodies · 01. July 2025
LO‑ME‑3, a rat anti-mouse IgE monoclonal antibody developed and manufactured by SynAbs, is a high-affinity reagent for in vitro R&D use only (RUO). It is validated in dozens of peer-reviewed studies as a core tool in allergy, asthma, and immunoassay workflows.
New primary monoclonal antibodies · 13. May 2025
MCR-1-mediated colistin resistance detection using SYnAbs monoclonal antibodies
Secondary monoclonal antibodies · 06. May 2025
Looking for a rat anti-mouse IgM antibody for your next ELISA or immunoassay?
LO-MM-3 by SynAbs is a high-affinity, RUO-grade monoclonal antibody trusted in murine immunology research. Ideal for in vitro diagnostics, B-cell assays, and antibody profiling, LO-MM-3 delivers consistency, specificity, and performance. Order LO-MM-3 today to power your next research-only immunoassay.
New primary monoclonal antibodies · 29. April 2025
SYnAbs unique primary monoclonal antibody to specifically detect vancomycin B (vanB) to tackle the threat of antibiotic resistance
New primary monoclonal antibodies · 23. April 2025
SYnAbs RUO monoclonal antibodies of mouse and rat species highly specific to Estradiol without cross-reactivity to close steroid analogs
New primary monoclonal antibodies · 22. April 2025
SYnAbs unique specific monoclonal antibodies for the detection of Vancomycin A without cross-reactivity to Vancomycin B or close analogs for antibiotic resistance diagnosis in lateral flow and other immunoassay formats
New primary monoclonal antibodies · 16. April 2025
SYnAbs unique R&D and therapeutic monoclonal antibodies to CCR10 (GPR-2), C-C chemokine Receptor 10 GPCR transmembrane protein
New primary monoclonal antibodies · 15. April 2025
SYnAbs offers the complete portfolio of mouse and rat isotype controls IgG1, IgG2a, IgG2b, IgG2c, IgG3, IgA, IgE, IgM
SYnAbs S.A.
Rue Auguste Piccard, 48
I-Tech Incubator 2
B-6041 Gosselies
Belgium
BE 0637.716.206
